TherapeuticsMD Inc (NYSE MKT LLC:TXMD)
| 4.34 Data as of Jan 27 |  -0.10 / -2.25%Today’s Change | 3.42 Today|||52-Week Range 9.01 | -2.47% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2010 | 2011 | 2012 | 2013 | |||
| Revenue and Income | Net Revenues | 48.2K | 2.1M | 3.8M | 8.8M | |
| Operating Expenses | Gross Income | -85.1K | 1.1M | 2.4M | 6.8M | |
| Total Operating Expenses | 516.2K | 7.5M | 20.0M | 34.8M | ||
| Non-Operating Expenses | Operating Income | -468.0K | -5.4M | -16.1M | -26.1M | |
| Extraordinary Credit | 0.00 | 0.00 | 0.00 | 250.0K | ||
| Extraordinary Charge | 0.00 | -7.4M | -17.0M | 0.00 | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -509.9K | -12.9M | -35.1M | -28.4M | |
| Net Income | -955.1K | -12.9M | -35.1M | -28.4M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 164.2K | 62.5M | 91.6M | 127.6M | |
| Shares To Calculate EPS Diluted | 164.2K | 62.5M | 91.6M | 127.6M | ||
| Earnings Per Share | EPS | -$4.00 | -$0.21 | -$0.38 | -$0.22 | |
| EPS Diluted | -- | -- | -- | -- | -- | |
.